^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    miransertib (MK-7075)

    i
    Other names: MK-7075 , ARQ-092, ARQ 092
    Associations
    News
    Trials
    Company:
    Merck (MSD), National Human Genome Research Institute
    Drug class:
    pan-AKT inhibitor
    Related drugs:
    Associations
    News
    Trials